Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-10-31T23:21:16.992Z Has data issue: false hasContentIssue false

Toxic epidermal necrolysis after paroxetine treatment

Published online by Cambridge University Press:  16 April 2020

P Wolkenstein
Affiliation:
Department of Dermatology, Hôpital Henri-Mondor, 94010Créteil, France
D Cremniter
Affiliation:
Department of Psychiatry, Hôpital Henri-Mondor, 94010Créteil, France
JC Roujeau
Affiliation:
Department of Dermatology, Hôpital Henri-Mondor, 94010Créteil, France

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © Elsevier, Paris 1995

References

Bodokh, ILacour, PhRosenthal, Eet al.Syndrome de Lyell ou nécrolyse épidermique toxique et syndrome de Stevens-Johnson après traitement par fluoxétine. Thérapie 1992; 47: 441Google Scholar
Freeman, CPFluvoxamine: clinical trials and clinical use. J Psychiatr Neurosci 1991; 16: 19–25Google ScholarPubMed
Menard, GAllain, HBeneton, CN'Guyen, JMEnquête épidémiologique sur la prescription d'antidépresseurs. Psychol Med 1992; 24: 1550–4Google Scholar
Srebmik, AHes, JPBrenner, SAdverse cutaneous reactions to psychotropic drugs Acta Derm Ven (Stockh) 1991; 71 (suppl 158): 3–12Google Scholar
Wagner, WPlekkenpol, BGray, TEVlaskamp, HEssers, HReview of fluvoxamine safety database Drugs 1992; 43 (suppl 2) 48–54CrossRefGoogle ScholarPubMed
Wolkenstein, PRevuz, JDiehl, JLLangeron, ORoupie, EMachet, LToxic epidermal necrolysis after fluvoxamine. Lancet 1993; 31: 304–5CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.